Royalty Pharma (RPRX) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of$1.11 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.41$1.1 per share when it actually produced earnings of $1.14, delivering a surprise of +3.64%.Over the last four quarters, the company ha ...